HK Stock Market Move | SMOORE INTL (06969) stock rises more than 4% as domestic regulations on electronic cigarettes gradually improve. The company's aerosol electronic cigarette business sector is steadily recovering.
Sinopharm International (06969) rose more than 4%, as of the time of publication, up 4.50%, at a price of HK$10.68, with a trading volume of HK$1.04 billion.
SMOORE INTL (06969) rose by more than 4%, reaching a 4.50% increase by the time of drafting, at HK$10.68, with a trading volume of HK$1.04 billion.
On the news front, recently, the State Tobacco Monopoly Administration issued a notice on revising and issuing the Electronic Cigarette Trading Management Regulations. It mentions the establishment of a national unified electronic cigarette trading management platform by the administrative authority of the State Tobacco Monopoly. Various types of electronic cigarette market entities that have obtained a tobacco monopoly license should conduct transactions through the platform. Caitong pointed out that the gradual improvement of domestic electronic cigarette regulations will promote the orderly and standardized development of the market. In the long run, non-compliant products will gradually be eliminated, market share is expected to further consolidate, benefiting production, brands, and other advantages of leading companies in various links.
Huatai noted that recently, boosted by the overseas interest rate cuts and the warming sentiment in the Hong Kong stock market, the leading vaporization device company SMOORE INTL's stock price has been boosted again. The company's traditional vaporized electronic cigarette business is steadily recovering, and H2 of 24H is expected to see a turning point in operations. Meanwhile, non-combustible heating, medical vaporization, and other businesses are steadily progressing as medium- to long-term strategic initiatives, with a smooth long-term growth logic. Additionally, Huaan pointed out that the company's layout in vaporized medical/beauty/HNB businesses is expected to gradually enter a volume expansion stage, providing new performance increments.
Related Articles

New stock news: Beijing GeoEnviron Engineering & Technology, Inc. (603588.SH) has submitted documents to the Hong Kong Stock Exchange.

New stock news | China Resources Pharmaceutical Group submits its listing application to the Hong Kong Stock Exchange again.

New stock news | Oral care brand "Canban" parent company Xiaokuo Group submitted an application to the Hong Kong Stock Exchange.
New stock news: Beijing GeoEnviron Engineering & Technology, Inc. (603588.SH) has submitted documents to the Hong Kong Stock Exchange.

New stock news | China Resources Pharmaceutical Group submits its listing application to the Hong Kong Stock Exchange again.

New stock news | Oral care brand "Canban" parent company Xiaokuo Group submitted an application to the Hong Kong Stock Exchange.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


